For the purpose of providing a GSK-3β inhibitor containing an oxadiazole compound or a salt thereof or a prodrug thereof useful as an agent for the prophylaxis or treatment of a GSK-3β-related pathology or disease, the present invention provides a GSK-3β inhibitor containing a compound represented by the formula (I):
wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof.
为了提供一种含有噁二唑化合物或其盐或其前药的GSK-3β
抑制剂,用作GSK-3β相关病理或疾病的预防或治疗剂,本发明提供了一种含有由以下式(I)表示的化合物的GSK-3β
抑制剂:
其中每个符号如规范中定义,或其盐或其前药。